Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (253)
- Medicine safety (170)
- Prescription medicines (154)
- COVID-19 (144)
- Regulatory compliance (135)
- COVID-19 vaccines (88)
- Legislation (84)
- Therapeutic goods regulation (75)
- Listed medicines (61)
- Non-prescription medicines (56)
- Safety (51)
- Medical devices safety (49)
- Complementary medicines (44)
- Manufacturing (40)
- Vaping hub (40)
- Over the counter (OTC) medicines (35)
- Australian Register of Therapeutic Goods (ARTG) (30)
- Labelling and packaging (30)
- Assessed listed medicines (26)
- Compliance and enforcement hub (25)
- Alert/Advisory (24)
- Scheduling (national classification system) (24)
- Medicinal cannabis hub (22)
- Import and export (21)
- Shortages (13)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (11)
- Weight loss products (11)
- Biological medicines (6)
- Advisory bodies and committees (5)
- Cosmetics (4)
- Registered complementary medicines (4)
- Unique Device Identification (UDI) hub (4)
- Blood and blood components (3)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Advanced therapies (1)
- Blood safety (1)
- Breast implant hub (1)
- Travelling with health products (1)
Search
1129 result(s) found, displaying 126 to 150
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
NewsThe Scheme allows businesses to surrender certain quantities of vaping goods that were lawful prior to 1 July 2024. Notify us before September 2024 to participate.
-
Media releasesInfringement notices were issued to businesses and individuals for the alleged unlawful advertising of prescription-only medicines on their websites.
-
Media releasesTGA has issued 3 infringement notices totalling $56,340 to News Life Media Pty Ltd for alleged unlawful advertising of medicinal cannabis on their popular lifestyle website Body+Soul.
-
Compliance undertakingsWe have accepted an enforceable undertaking from 2San Pty Ltd in relation to breaches of the Therapeutic Goods Act 1989. This relates to the company's unlawful import and supply of medical devices.
-
2San Pty Ltd enters into enforceable undertaking after unlawful import and supply of medical devices
Media releasesThe company imported medical devices not included in the Australian Register of Therapeutic Goods. They supplied these devices to a national retailer, who then sold them to the public. -
Media releasesThe Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024 will take effect on 1 July 2024, following passage through the Australian Parliament.
-
NewsFind out about regulatory changes to a range of medical devices and application audit requirements.
-
Media releasesTGA has issued 35 infringement notices totalling $627,252 to 6 businesses and 2 individuals for the alleged unlawful advertising of medicinal cannabis on their websites and social media platforms.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
NewsPrescription lenses supplied only for refractive correction are now exempt from inclusion in the Australia Register of Therapeutic Goods (ARTG) prior to import, export or supply in Australia.
-
Media releasesTGA has commenced proceedings in the Federal Court of Australia against Key Promotional Products Pty Ltd, and an individual, for allegedly importing and supplying unapproved rapid antigen test kits
-
Media releasesAmendments to the Therapeutic Goods Regulations 1990 (Schedule 5, item 6) have been made resulting in compounded GLP-1 RA products no longer being able to be compounded by pharmacists and supplied to patients.
-
NewsThe Bill is part of reforms to prevent and reduce the use of vapes in Australia, unless clinically appropriate for stopping smoking or the management of nicotine dependence.
-
NewsAnnex 16 will apply to therapeutic goods manufactured from 3 September 2024. Find out about the transition period.
-
NoticesFind out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2024, which commenced on 14 June 2024.
-
NoticesThis instrument is the Therapeutic Goods (Poisons Standard) (Benzylpenicillin—Seqirus) Approval 2024.
-
NewsWe are reviewing the safety information supporting notifications of the highest-risk medical devices used in first-in-human clinical trials. Find out how the changes we have implemented impact you as a sponsor.
-
Media releasesThe director of Elite Labs Pty Ltd was sentenced to 2 years imprisonment for his role in the unlawful manufacture, supply, advertising and export of performance and image enhancing therapeutic goods.
-
BlogOne of the key functions of the Therapeutic Goods Administration (TGA) is to closely monitor the safety of therapeutic goods. But to properly monitor safety, we need everyone to report any side effects and problems they have.
-
BlogSome online health clinics are advertising and selling compounded medicines. However, it is important to know that compounded products are not identical to TGA approved products.
-
Media releasesAn infringement notice of $18,780 has been issued to Myers Pharmacy Pty Ltd for the alleged unlawful advertising of Ozempic, a prescription-only medicine.
-
Safety updatesThe Product Information documents for antidepressants have been updated with warnings about sexual dysfunction continuing in some patients, after they stop using the medicines.
-
Media releasesInfringement notices totalling $171,972 have been issued to Better Leaf Pty Ltd, and an individual, for the alleged unlawful advertising of medicinal cannabis on its website and social media.
-
Safety updatesMedicines Safety Update - Information for health professionals